SOX21-AS1 has been verified as an oncogene in tumor progression, as it is highly expressed in lung adenocarcinoma, hepatocellular carcinoma, and colorectal cancer and predicts poor prognosis (46–48). This evidence concerns the gene SOX21 and colorectal cancer.